Literature DB >> 15603949

Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design.

Takayoshi Suzuki1, Azusa Matsuura, Akiyasu Kouketsu, Hidehiko Nakagawa, Naoki Miyata.   

Abstract

In order to find novel non-hydroxamate histone deacetylase (HDAC) inhibitors, we synthesized several suberoylanilide hydroxamic acid (SAHA)-based compounds designed on the basis of the catalytic mechanism of HDACs. Among these compounds, 5b was found to be as potent as SAHA. Kinetic enzyme assays and molecular modeling suggested that the mercaptoacetamide moiety of 5b interacts with the zinc in the active site of HDACs and removes a water molecule from the reactive site of the deacetylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15603949     DOI: 10.1016/j.bmcl.2004.10.074

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

Review 1.  Macrocyclic histone deacetylase inhibitors.

Authors:  Sandra C Mwakwari; Vishal Patil; William Guerrant; Adegboyega K Oyelere
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  Synthesis and evaluation of N⁸-acetylspermidine analogues as inhibitors of bacterial acetylpolyamine amidohydrolase.

Authors:  Christophe Decroos; Christine M Bowman; David W Christianson
Journal:  Bioorg Med Chem       Date:  2013-06-01       Impact factor: 3.641

3.  Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.

Authors:  Pei-Chia Chan; Chun-Yi Wu; Lin-Shan Chou; Chung-Hsien Ho; Chi-Wei Chang; Shih-Hwa Chiou; Wuu-Jyh Lin; Fu-Du Chen; C Allen Chang; Jeng-Jong Hwang; Ren-Shyan Liu; Hsin-Ell Wang
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

4.  Computational exploration of zinc binding groups for HDAC inhibition.

Authors:  Kai Chen; Liping Xu; Olaf Wiest
Journal:  J Org Chem       Date:  2013-04-29       Impact factor: 4.354

5.  In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors.

Authors:  Roula Konsoula; Mira Jung
Journal:  Int J Pharm       Date:  2008-05-13       Impact factor: 5.875

6.  Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors.

Authors:  Zacharoula Konsoula; Hong Cao; Alfredo Velena; Mira Jung
Journal:  Mol Cancer Ther       Date:  2009-09-29       Impact factor: 6.261

Review 7.  Recent advances in the search for antiviral agents against human papillomaviruses.

Authors:  Amélie Fradet-Turcotte; Jacques Archambault
Journal:  Antivir Ther       Date:  2007

8.  Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.

Authors:  Zacharoula Konsoula; Mira Jung
Journal:  Biol Pharm Bull       Date:  2009-01       Impact factor: 2.233

9.  Search for the pharmacophore of histone deacetylase inhibitors using pharmacophore query and docking study.

Authors:  Atefeh Haji Agha Bozorgi; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

10.  Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors.

Authors:  Matthias G J Baud; Thomas Leiser; Vanessa Petrucci; Mekala Gunaratnam; Stephen Neidle; Franz-Josef Meyer-Almes; Matthew J Fuchter
Journal:  Beilstein J Org Chem       Date:  2013-01-15       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.